- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05513105
Iron Study of Neonates Iron Study of Neonates Birth in Assuit University Children's Hospital
Iron Study of Neonates: Factors Affecting and Impact on Their Health Status at Birth in Assuit University Children's Hospital
Study Overview
Status
Intervention / Treatment
Detailed Description
Iron is an essential micronutrient that plays a significant role in critical cellular functions in all organ systems in all species. Iron is particularly vital for early brain growth and function in humans since it supports neuronal and glial energy metabolism, neurotransmitter synthesis and myelination [1-5]. The need to establish standard curves for cord serum ferritin concentrations throughout the third trimester of pregnancy is based on the risk of developing brain iron deficiency as storage iron pools become depleted in certain gestational conditions [6-8]. Iron deficiency during the fetal or postnatal periods can alter brain structure, neurochemistry and cognitive functioning, and lead to long-term cognitive and motor impairment that cannot be corrected by iron supplementation [9-11]. Newborn infants with the lowest quartile of cord ferritin concentrations (<76 μg/l) have impaired mental and psychomotor function at school age [12]. Iron-deficient infants of diabetic mothers (IDM) with low neonatal ferritin concentrations (<35 μg/l) have impaired auditory recognition memory processing at birth compared with iron-sufficient IDM (ferritin >35 μg/l) [13]. Pre-term infants with low serum ferritin concentrations (<75 μg/l) at 37 weeks post-conception have abnormal neurologic reflexes [14].
Direct measurement of brain iron in newborn infants is not currently feasible.Total body iron and iron storage estimates are based on measurements of serum markers, such as hemoglobin (Hgb) and ferritin concentrations [15]. Serumferritin concentration has been used as a standard measurement of iron stores ininfants, children and adults [16-19]. The relationships between ferritin concentrations and total body storage iron in these populations are well established. In adults, 1 μg/l of serum ferritin is equivalent to 8-10 mg ofstorage iron [20]. In newborn infants, the ratio of serum ferritin to liver nonheme iron concentration is closer to 1:2.7 [21]. In spite of the wide availability of serum ferritin as a screening test, normative data at birth, as a function of specific gestational ages from 23 to 41 weeks,
Low serum ferritin concentrations are seen only in iron deficiency. Elevated ferritin concentrations in the newborn can be a consequence of neonatal hemochromatosis, excessiveiron administration or RBC transfusions. Serum ferritin concentrations are also elevated during periods of infection,inflammation and neoplasia. Under these conditions, serum ferritin behaves as an acute-phase reactant that can mask the diagnosis of iron deficiency [22]. Iron requirements in women are significantly higher in the pregnant state than in the nonpregnant state. The total iron requirement of a full-term pregnancy is approximately 1,000 mg [23]. Iron requirements for pregnant women increase significantly in the second and third trimesters, with the expansion of maternal blood volume and fetal red cell mass [23]. The fetus accumulates iron at a rate of 1.35 mg/kg of fetal weight in the third trimester, maintaining an average iron content of 75 mg/kg of body weight during the last trimester [24.25]. At term, 70-80% of fetal iron is present in RBCs as Hgb, 10% in tissues as myoglobin and cytochromes, and the remaining 10-15% stored in reticuloendothelial and parenchymal tissues as ferritin and hemosiderin [24]. The placenta serves as the regulatable conduit for maternal-fetal iron transport. The amount of iron passing through the placenta increases with gestation. Iron is transferred against a concentration gradient from the placenta to the fetus, especially during the later stages of pregnancy. The placenta can also serve as a storage organ for iron during pregnancy.
Factors that influence neonatal ferritin concentration at birth include duration of gestation, fetal sex, maternal iron status and conditions altering maternal-fetal iron exchange.. At- or near-term female newborn infants have higher cord serum ferritin concentrations than male
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Ahmed Hashem
- Phone Number: 01553198012
- Email: ghh32539@gmail.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Neonates delivered at women Assuit university hospital either ceserian or normal vaginal delivery
Exclusion Criteria:
*Congenital malformation
- history of genetics or chromosomal disease
- history of inborn errors of metabolic disease
- Neonates who we cannot catch cord blood sample immediate afer birth
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Crossover
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Iron study of neonates
Time Frame: 3years
|
describes iron study of neonates affecting health status at birth
|
3years
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Asiout
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Iron study of neonates
-
Alberta Health Services, CalgaryPharmacosmos A/SNot yet recruitingGynecologic Cancer | Surgery | Anemia, Iron Deficiency
-
Riverside University Health System Medical CenterTerminated
-
Ain Shams UniversityCompletedRespiratory Distress Syndrome, NewbornEgypt
-
Lucie FavreNot yet recruitingRoux-en-Y Gastric Bypass | Hypophosphatemia
-
Chonbuk National University HospitalCompleted
-
University of British ColumbiaHelen Keller International; NCHADS - Ministry of Health of Cambodia; BC Children... and other collaboratorsCompletedInflammation | Anemia | Anemia, Iron Deficiency | Intestinal Inflammation | Intestine; ComplaintsCambodia
-
Swiss Federal Institute of TechnologyUniversité d'Abomey-CalaviCompletedIron Deficiency | BiofortificationBenin
-
The University of Texas Health Science Center,...CompletedIron Deficiency AnemiaUnited States
-
University of MinnesotaEnrolling by invitationIron-deficiency | Anemia | Malaria | Iron Deficiency Anemia | Anemia, Iron Deficiency | Anemia in ChildrenUganda